Nationwide Fund Advisors’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
KKRC
Nationwide Fund Advisors's AMED Position: Q4 2017 in Review
Nationwide Fund Advisors sold out of Amedisys (AMED) in Q4 2017, closing a stake of 154,763 shares — an estimated $8.66M sold.
Nationwide Fund Advisors first reported a position in AMED in Q2 2013 and held it in 17 quarters. The position peaked at $8.74M in Q2 2017. 188 funds tracked by Wall St. Rank hold AMED as of Q4 2017.
- Nationwide Fund Advisors reported no remaining Amedisys position as of Q4 2017 after selling out during the quarter.
- Nationwide Fund Advisors sold 154,763 Amedisys shares in Q4 2017, an estimated $8.66M.
- Nationwide Fund Advisors first reported a position in Amedisys in Q2 2013 and held it in 17 quarters.
- Nationwide Fund Advisors's Amedisys position peaked at $8.74M in Q2 2017.
- 188 funds tracked by Wall St. Rank held Amedisys as of Q4 2017.
Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.